Global Market Study on Spinal Cord Trauma Treatment: Surgery to Remain the Most Attractive Treatment Type for Spinal Cord Trauma

Spinal Cord Trauma Treatment  Market
  • Published On : Sep-2017 |
  • Pages : 183 Pages |
  • Format :

Global Spinal Cord Trauma Treatment Market: Overview

Persistence Market Research represents the historical global spinal cord trauma treatment market grown from 2012 to 2016 end. We have forecasted the global spinal cord trauma treatment market to grow from more than US$ 2,270 Mn in 2017 to more than US$ 3,000 Mn by 2025 end. This represents CAGR of 3.7% over the forecast period of 2017–2025. The global market for spinal cord trauma treatment represents absolute $ opportunity of close to US$ 90 Mn in 2018 over 2017 and incremental opportunity of close to US$ 760 Mn between 2017 and 2025.

With more than 85% revenue share, the surgery segment by treatment type likely to lead the global spinal cord trauma treatment market throughout the forecast period

Surgery segment dominated the global spinal cord trauma treatment market in revenue terms in 2016 and is projected to continue to do so throughout the forecast period. Surgery segment market was valued more than US$ 1,900 Mn in 2016 and is projected to be valued more than US$ 2,600 Mn in 2025 growing at a CAGR of 3.6% during the forecast period. Corticosteroids segment is expected to be the second most lucrative segment in the global spinal cord trauma treatment market, with attractiveness index of 0.4 during the forecast period.

Report Global Spinal Cord Trauma Treatment Market  Image for Market Bytes

Limited number of spinal cord trauma treatment centers hinders the growth of the market in MEA

Spinal cord trauma is generally treated in the emergency unit and specific trauma centers. But in the Middle East & Africa region only a limited number of these centers are available. Lack of availability of proper treatment facility is stalling the growth of the spinal cord trauma treatment market. Person who is suffered with the spinal cord trauma has higher chances of death in African region due to limited access to the emergency healthcare facility.

High cost of surgical procedures to treat spinal cord injuries is a growth stalling factor in APAC

Spinal cord trauma is currently being treated with the surgical procedure but this procedure does not cure disorder but only prevent worsening of condition. Majority of the population in

Asia-Pacific region is not covered under healthcare insurance and patient themselves have to pay for the procedures. High cost of these procedure and low end result is expected to discourage the family of patients to opt for the surgical procedure which is acting as restraint factor in the market growth.

Increasing research on alternative treatments to hamper revenue growth of the Europe surgery market

Currently used treatment modalities in Europe has limited therapeutic impact on improving patient condition with spinal cord trauma. So, in order to provide better treatment and improve condition of patients, investment on development of alternative treatment modalities is increasing. Various companies are conducting research on treatment options such as, stem cell therapy and nerve regeneration therapy. Development of these therapies will reduce the use of less effective treatment methods that are being used.

Ineffectiveness of surgery in curing spinal cord injuries in Latin America

Usually, decompression therapy and surgery are used for the management of spinal cord trauma. But these procedure can not cure the condition. These procedures are used to prevent worsening of the spinal cord trauma condition. But Latin America countries where financial condition is a major factor while deciding the treatment approach and if, a procedure can not completely cure the condition then people or family of patient might not select surgical procedure as a preferred choice of treatment. So, an ineffectiveness of spinal surgery in delivering the required cure is a factor that is restricting the growth of market.

Availability of alternative treatment options in North America

Corticosteroids, spinal traction followed by decompression surgical procedure are the most preferred choices for the treatment of spinal cord trauma. But these procedures cannot reverse the damage caused to the spinal cord. In order to leverage the presence of larger patient pool, various biopharmaceutical and medical devices companies are developing treatment options that can improve the sensory function and treat damaged nerves. These alternative treatment modalities are expected restrain the growth of spinal cord trauma treatment market.

Before coming up with this brand new report on global spinal cord trauma market, the analysts at Persistence Market Research have inspected the global as well as regional markets in detail. One of the most important aspect of this report is, our expert team of analysts who are working extensively in healthcare domain have focused on forecast factors and have offered the unique perspective and assumptions on the market force. Pricing analysis, value chain analysis and list of active key participants are some of the other features of this recently published report titled, “Spinal Cord Trauma Treatment Market: Global Industry Analysis 2012 – 2016 and Forecast 2017 – 2025.” To give a crystal clear picture of the market to our clients our analysts went extra miles to give detail information about market size, forecast, drivers, restraints, trends and opportunities of all the five regions that have been covered in this report. Apart from regional insights, we have also given comprehensive information on various segments and its sub-segments. For the better understanding of the entire market, we have divided the market based on treatment type, injury type, end user and region segments.

The report provides key strategic recommendations for existing and new players in the market

Primarily, the report takes an overview of the global spinal cord trauma treatment market. The overview mainly consists of market taxonomy which underlines factors influencing the growth of the global spinal cord trauma treatment market. It is followed by the list of spinal cord trauma treatments in pipeline. Bottom-up approach has been used to assess market numbers for each product category, while top-down approach has been used to counter-validate the reached numbers for global spinal cord trauma treatment market. Macro-economic indicators such as healthcare industry outlook, healthcare spending, research funding, Gross Domestic Product and others have been considered to arrive at the indicated market numbers.  

This report covers the global spinal cord trauma treatment market performance in terms of revenue contribution from various segments. This section also includes Persistence Market Research analysis of key trends, drivers, restraints and opportunities, which are influencing the growth of the global spinal cord trauma treatment market. Impact analysis of key regional growth drivers and restraints based on the weighted average model along with key region-specific trends is included in a report to better equip clients with information and hidden insights. This market company has provided a key strategic recommendation for both existing and new players in the market to emerge sustainably profitable.

In the final section of the report, global spinal cord trauma treatment market landscape is included to provide report audiences with a dashboard view on the basis of categories of providers across the market, their presence in global spinal cord trauma treatment market and key differentiators.

Key segments covered in this report

By Treatment Type

  • Corticosteroid
  • Surgery
  • Spinal Traction

By Injury Type

  • Complete Spinal Cord Injuries
  • Partial Spinal Cord Injuries

By Region

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East & Africa

By End User

  • Hospitals
  • Trauma Centers

In-depth secondary research is the key to ascertain overall market size and top products

The forecast presented in report assesses total revenue of the global spinal cord trauma treatment market. When developing the forecast of the market, the starting point involves sizing the current market, which forms the basis for the forecast of how the market is anticipated to take shape in the near future. Given the characteristics, we triangulated the outcome on the basis of analysis based on supply and demand sides. However, quantifying the market across the aforementioned segments and regions is more a matter of quantifying expectations and identifying opportunities rather than rationalising them after the forecast has been completed.

The report also takes into consideration year-on-year growth to understand the predictability of the global spinal cord trauma treatment market and to identify the right opportunities across the market. As previously highlighted, the market for spinal cord trauma treatment is split into various categories. All these segments have been analysed in terms of BPS to understand the individual segment’s relative contribution to the market growth. This detail information is important for the identification of various key trends in the global spinal cord trauma treatment market. 

Company Profiles

  • Acorda Therapeutics, Inc. 
  • Asterias Biotherapeutics 
  • ReNetX Bio. 
  • BioArctic AB 
  • BioTime, Inc. 
  • InVivo Therapeutics 
  • Kringle Pharma, Inc. 
  • Novartis AG 
  • Pfizer Inc. 
  • Pharmicell Co. Ltd. 
  • Vertex Pharmaceuticals Inc. 
  • Bioaxone Biosciences, Inc.
  • Others.
Back To Top